Pharmacovigilance and expedited drug approvals

Aust Prescr. 2018 Apr;41(2):50-53. doi: 10.18773/austprescr.2018.010. Epub 2018 Apr 3.

Authors

Matthew Linger¹, Jennifer Martin²

Affiliations

¹ Royal Brisbane and Women's Hospital.
² Hunter New England Health, Newcastle, New South Wales.

No abstract available

Keywords: Therapeutic Goods Administration; adverse effects; drug regulation; postmarket surveillance.

Publication types

Review